Spring Grove research (historical)

1. Introduction

Version followed: the "psychedelic-peak" therapy of the Spring Grove State Hospital research unit / Maryland Psychiatric Research Center (MPRC), Catonsville, Maryland, as its staff published it in Pahnke, Kurland, Unger, Savage & Grof (c. 1970), Pahnke (1969), Richards, Grof, Goodman & Kurland (c. 1972–73), Savage & McCabe (1973) and Richards (1979–80). Historical account: not for use. This guide gives no doses, routes, schedules or other administration details. It describes the psychotherapy and safety frame in general terms, then sets out what a clinician today does with this knowledge.

What it was. Spring Grove was not one therapy. It was a state-hospital research programme funded by the National Institute of Mental Health (NIMH). It began with an observational study in chronic schizophrenia in 1955. It ran formal LSD-assisted psychotherapy studies from 1963, moved into the new MPRC in 1969, and ended in 1976 [source: Wikipedia, Spring Grove Experiment; MAPS, LSD Research in the 1990's]. The populations studied were:

• people with chronic alcoholism (the main controlled study);
• outpatients with neurosis;
• incarcerated men with heroin addiction (a randomised residential study);
• people with terminal cancer who had depression, anxiety, isolation or pain. This was treatment of psychological distress, not of the cancer;
• health professionals seeking training sessions.

[source: Pahnke et al. c.1970; Savage & McCabe 1973; Richards et al. c.1972; MAPS 1990s article]

People. Albert Kurland was the director. Charles Savage and Sanford Unger were early research leaders. Walter Pahnke was Director of Clinical Science; Leuner says the alcoholism research was "led first by Pahnke and later by Grof". Stanislav Grof, William Richards, Richard Yensen, O. Lee McCabe and others were clinicians and researchers [source: Wikipedia; Leuner c.1993; MAPS]. Grof, Pahnke and Richards were central staff. Kurland, Savage and Unger were equally central and led the work before Pahnke and Grof arrived.

Core idea of change (as the authors stated it). The aim was a single, intensely prepared drug-session day that would produce a "peak" or mystical-type experience. That experience was built into a larger course of drug-free psychotherapy before and after the session. The authors held that the experience, when integrated, could shift outlook, motivation and relationships quickly. They saw the drug as necessary but not sufficient: the authors wrote that "LSD is not a substitute for skilled psychotherapy". Richards later described the drug session as an "opportunity for the resolution of conflicts" rather than an experience valuable in itself [source: Pahnke et al. c.1970; Pahnke 1969; Richards 1979–80].

Legal and regulatory status. LSD has been in Schedule I of the US Controlled Substances Act since the early 1970s, defined as having no accepted medical use [source: University of Calgary 2016 news piece]. The 1991 US Food and Drug Administration (FDA) approval of an MPRC-lineage protocol for substance use never led to treatment, because no drug supply could be obtained [source: Wikipedia; MAPS]. Present-day status in the UK, the EU, Canada and Australia is not covered here [uncertain]. In those jurisdictions LSD is generally understood to be controlled and outside routine clinical use [synthesis]. No legal clinical practice of the Spring Grove method exists today.

2. Framework

The framework below is historical: it is how the programme was run, not a protocol to follow [source: Pahnke et al. c.1970; Richards et al. c.1972; Savage & McCabe 1973; Richards 1979–80].

Programme timeline.

• 1955: observational study of reactions in chronic schizophrenia. Responses were classed as "covert", "intensification" and "reversal".
• 1963–c.1970: alcoholism studies. A preliminary report appeared in 1967 and a controlled study was reported in 1970–71.
• c.1965/66–1970s: pilot programme for terminal cancer. It later also used DPT, a shorter-acting compound, because the long day was a burden on staff.
• c.1969–72: controlled residential study of narcotic addiction.
• Late 1960s–1970s: controlled neurosis study and training sessions for professionals.
• 1976: the state ended psychedelic research.

[source: Wikipedia; Pahnke et al.; Richards et al.; MAPS] Exact start dates differ between sources by a year or two [uncertain].

Phases of a treatment course in the psychedelic-peak model:

1. Referral, screening and consent. Goal: select patients who could tolerate an intense experience and exclude those at medical or psychiatric risk. Written informed consent was obtained, and for cancer patients a close relative also signed.
2. Drug-free preparatory psychotherapy. Goal: build rapport and "an atmosphere of basic trust", which Richards et al. called the most important variable. The therapist also learned the patient's history and defences and prepared the patient to let go of usual ego controls. Published length: about 20 hours on average for the psychedelic-peak work (Pahnke et al.); about 6–12 hours over 2–3 weeks for cancer patients (Richards et al.); about ten hours over 2–3 weeks (Richards 1979–80); several weeks in the addiction study. Leuner reports a 4-week pre-treatment for the alcoholism study.
3. Orientation the day before. Goal: explain the procedure and the setting, meet the nurse co-therapist, and practise listening to music with eyeshade and headphones.
4. Session day. Goal: a supported, inward-focused, day-long experience with a therapist and a nurse present throughout. The patient used eyeshade and headphones with selected classical music, and there were brief check-ins. In the cancer work, family visited at the end of the day.
5. Post-session integration. Goal: review the experience, apply insights to daily life and relationships, and use the "afterglow" period. This included next-day contact, a written or dictated account, and further sessions over the following week or so. Family therapy often moved forward at this stage.
6. Research follow-up. Goal: outcome rating. Alcoholism measures were taken at 6, 12 and 18 months. Cancer measures were taken the day before and three days after the session. The addiction study used 12 months of urine surveillance and parole-agent interviews.

Criteria for moving between phases. The published criterion was clinical judgement. In the addiction study the drug session was scheduled only when the therapist judged that the relationship could "withstand" an intense experience [source: Savage & McCabe 1973]. No numeric readiness criteria were published.

Variants.

• Cancer work used shorter preparation, more family therapy and a private hospital room [source: Pahnke et al.; Richards et al.].
• Addiction work used a roughly six-week residential halfway-house stay, then entry into a regular outpatient clinic [source: Savage & McCabe 1973].
• Alcoholism and neurosis work used a living-room-style treatment suite [source: Pahnke et al.].

What was claimed and found (short, for orientation only).

• Alcoholism: improvement at six months favoured the full-intensity condition over an active comparison condition, and was associated with peak experience. Leuner reports that differences in drinking behaviour were not significant at 12 and 18 months [source: Pahnke et al.; Leuner c.1993].
• Narcotic addiction: at least one year of verified abstinence in 25% of the treatment group versus 5% of controls. Global adjustment did not differ significantly [source: Savage & McCabe 1973].
• Cancer: about two-thirds improved on observer ratings in an uncontrolled pilot [source: Richards et al.; Pahnke et al.].

The authors themselves called the cancer data illustrative, not conclusive.

Why practice stopped.

• Pahnke died in 1971 [source: Wikipedia].
• A series of "unfortunate political episodes" led the Maryland government to stop the research in 1976 [source: MAPS].
• A regulatory shift towards randomised controlled trials suited an experience-based therapy poorly [source: Calgary/Oram].
• Hallucinogens became associated with the counterculture, and LSD was scheduled.
• Concern about chromosome damage was raised from 1969; the team's own controlled study found no increase.
• Funding cuts, media pressure, and blinding that failed because staff and patients could tell who had received the drug [source: Wikipedia; Pahnke et al.; Leuner].

Wikipedia also links the closure to publicity about MKUltra and Edgewood Arsenal. This is not confirmed in primary sources [uncertain].

3. Guiding principles

A. Principles the Spring Grove authors stated. These are historical, and they explain how the programme was designed.

• Set and setting determine the reaction [source: Pahnke et al.]. Practical meaning: the outcome was attributed as much to preparation, expectation and environment as to the drug.
• The drug is not a substitute for psychotherapy [source: Pahnke et al.; Richards 1979–80]. Practical meaning: studies with minimal psychotherapy did no better than controls, so the drug day sat inside a full course of therapy.
• Basic trust is the most important variable [source: Richards et al.]. Practical meaning: preparation hours were spent on the relationship before any session was scheduled.
• The peak experience is facilitative, not automatic or sufficient [source: Pahnke 1969; Savage & McCabe 1973]. Practical meaning: it occurred in only a minority of patients (cancer) or a majority (addiction), and change still depended on integration.
• Surrender and openness [source: Pahnke et al.]. Practical meaning: patients were prepared to let go of ego controls voluntarily and to stay open to whatever arose.
• "Being with" the patient [source: Richards 1979–80]. Practical meaning: an existential-humanistic stance. Support was mostly nonverbal, and absorbed patients were left undisturbed.
• Move towards, not away from, frightening material [source: Richards 1979–80]. Practical meaning: patients who were afraid were encouraged to confront the feared imagery. The authors viewed panic and paranoia, if sustained, as antitherapeutic.
• Honesty without forcing [source: Richards 1979–80; Pahnke 1969]. Practical meaning: no deception about diagnosis, but prognosis was discussed only as the patient was ready.
• The family is part of treatment in the cancer work [source: Pahnke 1969; Richards et al.]. Practical meaning: relatives were seen alone and with the patient, and family communication was a main target.
• No claim of physical cure [source: Pahnke et al.; Richards 1979–80]. Practical meaning: patients were told the treatment addressed coping and distress, not the cancer.
• Specialised, supervised training is essential [source: Richards et al.; Pahnke 1969]. Practical meaning: the authors advised strongly against use without such training. Pahnke likened the drug to a scalpel.
• The human encounter matters [source: Richards et al.]. Practical meaning: the authors credited much of the benefit to the relationship and to the therapists' enthusiasm, which is also a source of bias.

B. Principles for a clinician today [synthesis]:

• Not for use. Never replicate, facilitate or broker these sessions. Your role is history-informed assessment, harm reduction, integration and referral.
• Separate the transferable from the non-transferable. The drug-free elements belong to ordinary good practice: thorough preparation, family communication at end of life, honest consent, and structured debriefing. The drug elements remain within regulated trials only.
• Read the historical claims at their evidence level. The studies were small, uncontrolled or poorly blinded. Long-term follow-up was thin, and results were mixed beyond six months.
• Watch for consent and power problems. Prisoners and dying patients were the study populations, and Savage & McCabe themselves questioned whether volunteering in prison was truly voluntary.
• Treat lineage claims with care. Present-day practitioners may cite Spring Grove as authority. Two MPRC-trained clinicians (Yensen and Dryer) were later barred by MAPS and lost their licences for ethical violations [source: MAPS]. Training lineage does not guarantee safe practice.

4. Intervention inventory

This section has two parts. Part A records the historical Spring Grove/MPRC procedures as published. It is not for use, and it gives no drug or administration detail. Medical monitoring on session days was a medical-staff responsibility and is not described here. Part B gives what a present-day psychotherapist actually does with this history; Part B is mostly [synthesis].

Part A: Historical procedures (not for use)

A1. Referral, screening and exclusion

• Purpose: to select patients who could tolerate a long, intense experience and to exclude those at medical or psychiatric risk.
• Steps (as published):
  • Cancer patients were referred by oncologists or physicians and interviewed by a psychiatrist.
  • Cancer inclusion required distress (pain, depression, anxiety or isolation) and a life expectancy of at least three months.
  • Cancer exclusions were brain metastases or organic brain disease, recent heart attack or imminent cardiovascular risk, current or chronic psychosis, and gross or "prepsychotic" psychopathology.
  • Addiction-study screening used psychological testing and a physical examination. It excluded organic brain damage, active liver or cardiovascular disease and florid psychosis.
  • [source: Richards et al.; Richards 1979–80; Savage & McCabe 1973]
  • Alcoholism-study criteria are not stated in the sources [uncertain].
• Example language: none published. The authors told patients the treatment was meant to help them cope with the illness, not to treat it [source: Richards 1979–80].
• Watch for (today's lens): the published lists are short by modern trial standards. They do not mention bipolar disorder, family history of psychosis or medication interactions [synthesis].

A2. Informed consent

• Purpose: voluntary, informed participation.
• Steps (as published):
  • Risks and benefits were discussed with the patient and family, and written consent was obtained. In the cancer work a close relative also signed [source: Richards et al.; Pahnke 1969].
  • Prisoners were told they might or might not receive LSD [source: Savage & McCabe 1973].
• Example language: none published.
• Watch for: Savage & McCabe themselves questioned whether volunteering in prison was truly voluntary. Henry Beecher, a physician responding to Pahnke, raised consent and privacy concerns for dying patients [source: Savage & McCabe; Pahnke 1969 responses].

A3. Drug-free preparatory psychotherapy

• Purpose: to build trust and to learn the patient's history, dynamics and defences. It also prepared the patient to let go of usual controls. The authors regarded preparation as the most important variable.
• Steps (as published):
  • Interviews over several weeks covered the life story, relationships, philosophy and religious experience, and intrapsychic conflict [source: Pahnke 1969; Pahnke et al.].
  • With alcoholic and addicted patients, preparation also worked gently on self-defeating behaviour and on the lack of meaningful relationships [source: Savage & McCabe].
  • With cancer patients, deep trauma was deliberately not probed. The focus was living fully in the time remaining, unresolved family conflict, and facing the diagnosis as the patient was ready [source: Richards et al.].
  • Therapists were advised to watch their own anxiety about discussing prognosis [source: Richards et al.].
  • Medication review was a medical task and is not described here.
• Example language (illustrative, drug-free): "Before anything else, I want us to know each other well enough that you can trust me with whatever comes up."
• Watch for: much improvement occurred during preparation itself, before any drug session [source: Richards 1979–80]. This is one reason the drug's specific effect could not be isolated.

A4. Family meetings and family therapy (cancer programme)

• Purpose: to open communication, reduce pretence and isolation around dying, and prepare relatives.
• Steps (as published):
  • Relatives were seen individually, with the patient and as a group.
  • The meetings covered communication, fear of death and the relatives' questions about the treatment.
  • Before the session day the therapist met the family as a group to explain the rationale, allay fears and build cohesion.
  • Family work continued after the session, when it often "progressed noticeably".
  • [source: Pahnke 1969; Richards et al.]
• Example language (illustrative): "What has been hardest to say to each other since the diagnosis?"
• Watch for: in the published case examples, a patient asked directly about her diagnosis after her family had avoided it. Once she knew, she comforted her husband and planned conversations with her grandchildren [source: Pahnke 1969].

A5. Pre-session orientation

• Purpose: to reduce uncertainty and establish the alliance with the co-therapist.
• Steps (as published):
  • Procedures were explained in detail the day before, and the patient met the nurse co-therapist, who also assessed nursing needs.
  • The session was described as a "journey" with possible pleasant and unpleasant moments, and patients were reassured about their own strengths.
  • Patients practised wearing the eyeshade and listening to music on headphones.
  • [source: Richards et al.; Richards 1979–80]
• Example language: the published framing word was "journey" [source: Richards 1979–80]. No script is reproduced here.
• Watch for: none further published.

A6. Setting preparation

• Purpose: a safe, aesthetic and private environment that supports "set and setting".
• Steps (as published):
  • Alcoholism and neurosis sessions used a living-room-style suite with music equipment, flowers and art. Cancer sessions used a private hospital room with flowers, meaningful photographs or artwork, and a privacy sign on the door [source: Pahnke et al.; Richards et al.].
  • In the cancer programme the nurse gave the patient a single red rosebud, which often became a focus of attention [source: Richards et al.].
  • The addiction study used a small halfway-house unit [source: Savage & McCabe].
• Example language: not applicable.
• Watch for: none further published.

A7. Two-person team presence and conduct

• Purpose: continuous psychological support and safety.
• Steps (as published):
  • A psychiatrist or clinical psychologist and a trained psychiatric nurse were "in constant attendance". In the cancer work, the nurse stayed with the patient throughout [source: Pahnke et al.; Richards 1979–80].
  • Support was mainly nonverbal. The therapist sometimes held the patient's hand and encouraged the expression of feelings [source: Richards et al.].
  • Patients who were absorbed were largely left undisturbed, and the therapist intervened briefly only if needed [source: Richards 1979–80].
  • The addiction-study report centres on a single guiding therapist [source: Savage & McCabe].
• Touch policy: hand-holding is reported. No written touch policy or consent-to-touch procedure appears in the sources [uncertain]. Present-day regulated trials require explicit, pre-agreed touch policies [synthesis].
• Example language: none published.
• Watch for: the authors saw how the therapist handled difficult moments as important [source: Pahnke et al.].

A8. Eyeshade and music for inward focus

• Purpose: to turn attention inward and to help the patient release emotion and let go.
• Steps (as published): the patient reclined with an eyeshade and stereo headphones. Carefully selected classical music played for most of the day, alternating with conversation with the therapist [source: Pahnke et al.; Richards et al.]. Musical therapists joined the team later [source: Wikipedia]. The playlists are not published in the sources [uncertain].
• Example language: none published.
• Watch for: none further published.

A9. Brief check-ins and "collecting experiences"

• Purpose: to keep contact without interrupting absorption.
• Steps (as published): at intervals the eyeshade and headphones were removed for a short exchange. Patients were encouraged to "collect experiences" and discuss them later [source: Richards et al.].
• Example language (illustrative): "Just checking in. You can tell me more later if you like."
• Watch for: none further published.

A10. Encouraging confrontation of feared material

• Purpose: to move through, rather than flee, frightening content.
• Steps (as published):
  • Patients who were afraid were encouraged to face the feared imagery. Richards reports that confronting symbolic threats often led to resolution [source: Richards 1979–80].
  • Panic, paranoia and confusion were considered rare in supportive settings, and antitherapeutic when they persisted.
  • Fearful, mistrustful patients had more panic and abreaction [source: Savage & McCabe].
• Example language: none published.
• Watch for: the authors interpreted vomiting and other somatic symptoms as psychosomatic, linked to resistance or catharsis. They also noted genuine medical causes in cancer patients, such as obstruction [source: Richards et al.]. Today: never assume a physical symptom is psychological [synthesis].

A11. Family photographs late in the session (cancer programme)

• Purpose: to evoke memories and work on relational conflict.
• Steps (as published): photographs were sometimes shown late in the session [source: Richards et al.]. No further detail was published.
• Example language: none published.
• Watch for: none further published.

A12. Re-entry and family visit

• Purpose: to reconnect the patient with relationships while still open.
• Steps (as published): relatives visited at the end of the day at the therapist's discretion, and young children occasionally visited briefly [source: Richards et al.; Pahnke 1969]. Follow-up began during the re-entry period itself [source: Pahnke et al.].
• Example language: none published.
• Watch for: none further published.

A13. Written or dictated session account

• Purpose: to consolidate memory and supply material for integration.
• Steps (as published): the patient wrote or dictated a detailed account after the session [source: Pahnke et al.; Richards et al.].
• Example language: none published.
• Watch for: none further published. This element is transferable to drug-free work as ordinary debriefing practice [synthesis].

A14. Post-session integration sessions

• Purpose: to clarify confusing material and apply insights to everyday life and relationships.
• Steps (as published):
  • The therapist visited the next day and several times that week.
  • Free association was used, and also Leuner's guided affective imagery (Katathym imaginative psychotherapy) for confusing images.
  • The work focused on family and interpersonal conflicts [source: Richards 1979–80; Richards et al.].
  • Addiction patients had about a week of further therapy before discharge to the clinic [source: Savage & McCabe].
• Example language (illustrative): "Which part of yesterday do you want to carry into this week, and with whom?"
• Watch for: none further published.

A15. Using the "afterglow" window

• Purpose: to use a period of better mood and interpersonal openness, said to last from about two weeks to a month after a stabilised peak experience, for work on strained relationships [source: Pahnke et al.].
• Steps: therapy was intensified in that period. No further procedure was published.
• Example language: none published.
• Watch for: none further published.

A16. Residential halfway-house variant (heroin addiction)

• Purpose: treatment combined with a protected re-entry from prison.
• Steps (as published): about six weeks of residence on a small unit, with preparation, one session, integration and recreation. Discharge to the outpatient clinic followed once parole conditions such as a job and housing were met [source: Savage & McCabe 1973].
• Example language: none published.
• Watch for: the authors named three limitations [source: Savage & McCabe]:
  • unmotivated volunteers;
  • a cultural gap between the white therapist and mostly Black patients;
  • a design that could not separate drug, psychotherapy and residence.

A17. Outcome and experience assessment

• Purpose: to measure research outcomes.
• Steps (as published):
  • Observers rated patients on scales for depression, anxiety, isolation, fear of death and pain. Raters included physicians, nurses, family, therapists and an independent social worker [source: Richards et al.].
  • Personality inventories were used [source: Richards 1979–80; Leuner].
  • Urine surveillance and global adjustment ratings from parole-agent interviews were used in the addiction study [source: Savage & McCabe].
  • Post-session questionnaires rated peak experience.
  • Pahnke's typology lists nine characteristics of mystical experience: unity, transcendence of time and space, positive mood, sacredness, noetic quality, paradoxicality, alleged ineffability, transiency, and persisting positive change. He also listed four other experience types: psychotic, psychodynamic, cognitive and aesthetic [source: Pahnke 1969]. Wikipedia says eight criteria, so versions differ [uncertain].
  • Instrument items are not reproduced here.
• Example language: not applicable.
• Watch for: none further published.

Part B: What a clinician does with this knowledge today [synthesis]

B1. Asking about research or underground participation

• Purpose: to identify clients, often older adults, who took part in Spring Grove-era or other mid-century psychedelic research, or in later underground sessions that claimed this lineage. Also to identify relatives of such participants.
• When: at intake with older clients, with clients from Maryland or with prison histories, and whenever a client mentions "LSD therapy", "Spring Grove" or "Catonsville".
• Steps:
  • Ask openly and without judgement.
  • Record what the client remembers: setting, staff roles, consent, and what happened afterwards.
  • Ask what meaning the client gives it now, whether there are lasting effects (positive or negative), and whether there is unresolved distress.
  • Do not assume harm or benefit.
• Example language (illustrative): "Some people took part in hospital research with psychedelic drugs in the 1960s and 70s. Has anything like that been part of your history?"
• Watch for: shame, secrecy, and memories shaped by later media accounts. Ask about prison-era participation with special care because of the consent problems described above. Working signs: the client can tell a coherent account and name what it means to them.

B2. Helping clients evaluate historical claims

• Purpose: to correct over- or under-statement when clients cite Spring Grove as proof that LSD "cures alcoholism" or "cures fear of death".
• Steps:
  • Summarise the facts plainly. The studies were pioneering but small, poorly blinded and often uncontrolled. The six-month alcoholism gains were not sustained at 12–18 months on drinking measures. The addiction study showed better verified abstinence but not better global adjustment. The cancer data were an uncontrolled pilot.
  • Point out that the authors themselves said the drug was not a substitute for psychotherapy and that much change happened during preparation.
  • [source for facts: section 2]
• Example language (illustrative): "Those studies were serious and careful for their time. They also found that the preparation and the relationship did a lot of the work, and that the effects on drinking faded by a year."
• Watch for: working signs are that the client's expectations become more realistic and that they show curiosity about evidence-based options.

B3. Harm-reduction and integration support for clients using psychedelics outside regulated settings

• Purpose: to support safety without facilitating illegal use.
• Steps:
  • Assess the reasons for use, psychiatric history (psychosis, bipolar disorder, family history), cardiovascular and other medical issues, current medications, and suicide risk.
  • Give general education that interactions and medical risks exist, without discussing amounts, and advise speaking to a physician.
  • Make a safety plan for crises.
  • Refer to regulated clinical trials where they exist.
  • Offer post-experience integration sessions. Never source substances, recommend sitters or attend sessions.
• Example language (illustrative): "I can't help you plan a session, but I can help you think through the risks, and I'm here afterwards to make sense of whatever happens."
• Watch for: a client who cites Spring Grove-style "peak therapy" to justify a facilitator; signs of destabilisation after use; and the need for psychiatric referral.

B4. Integration work for a past psychedelic or mystical-type experience

• Purpose: to help a client make sense of a significant past experience, whether from a historical study, a trial or elsewhere. The drug-free elements of the published model inform this work: a written account, a focus on relationships, and applying insight to daily life [source for those elements: A13–A15].
• Steps:
  • Invite the client to write a narrative account.
  • Explore emotional, symbolic and relational themes with their own meanings; do not impose Pahnke's or anyone's metaphysics.
  • Identify one or two concrete changes in relationships or behaviour.
  • Monitor for depersonalisation, persistent perceptual changes, anxiety or loss of meaning, and refer to a psychiatrist if they occur.
• Example language (illustrative): "What did it seem to show you, and what, if anything, do you want to do differently because of it?"
• Watch for: spiritual or religious interpretations are the client's own framework. Attribute them and respect them, and neither endorse them as fact nor dismiss them.

B5. Transferable drug-free elements in end-of-life psychotherapy

• Purpose: to apply what the cancer programme emphasised that needs no drug: thorough relationship-building, honest but paced discussion of prognosis, family meetings to break pretence and isolation, and attention to the therapist's own death anxiety [source for those elements: A3–A4].
• Steps:
  • Hold joint and separate family meetings.
  • Explore what has gone unsaid.
  • Let the patient lead on prognosis.
  • Use supervision to examine your own discomfort.
• Example language (illustrative): "Is there anything you'd want your family to hear from you while there's time?"
• Watch for: working signs are more open communication and less isolation. For established structured approaches, refer to or train in evidence-based palliative psychotherapies; naming specific ones is beyond the sources [uncertain].

B6. Screening practitioners and services that claim Spring Grove lineage

• Purpose: to protect clients from unsafe or exploitative practice presented as a continuation of the Maryland work.
• Steps:
  • Check legal status, licensure and whether the service operates under an approved trial or a regulated programme.
  • Check the touch and consent policy, the two-person team, the medical screening and emergency arrangements, and the integration follow-up.
  • Treat claims of personal training with Grof or MPRC staff as irrelevant to present-day safety. MAPS states that two MPRC-trained clinicians were later barred for ethical violations [source: MAPS].
• Example language (illustrative): "Being trained by famous people decades ago doesn't tell us whether this service is legal or safe now. Let's look at what they actually do."
• Watch for: unlicensed practice, secrecy, sexual or financial boundary problems, and discouraging medical care. Such practices may raise reporting duties under your licensing rules [synthesis].

5. Handling problems

Problems the Spring Grove authors reported, with their published responses (historical):

• Fear, panic, paranoia, abreaction. Response: preparation for trust and encouragement to confront the feared imagery. Patients high in fear or mistrust were more prone to these reactions [source: Richards 1979–80; Savage & McCabe].
• Nausea, vomiting, tremor, palpitations, breathing difficulty. Response: the authors interpreted these as psychosomatic. In cancer patients they also recognised medical causes such as obstruction and incontinence, which needed nursing care [source: Richards et al.]. Today's caution [synthesis]: treat every somatic symptom as medical until a physician has cleared it.
• Fatigue in medically ill patients. Benefits often appeared only on the second day [source: Richards et al.].
• Non-response. About a third of the cancer pilot showed no clear benefit, and peak experiences occurred in only a minority. The authors did not present this as a failure of the patient [source: Pahnke 1969; Richards et al.].
• Post-session psychiatric disturbance. Pahnke et al. report two such disturbances among more than 300 patients, both of which responded to conventional treatment [source: Pahnke et al.]. A death from aortic stenosis occurred in the addiction study months later and was not attributed to treatment [source: Savage & McCabe].
• Withdrawal from the study. In the addiction study, four inmates assigned to treatment transferred to the regular programme [source: Savage & McCabe]. No other non-adherence data were published.
• Staff burden. The long sessions required a heavy time commitment from the therapist and nurse, which motivated the search for shorter-acting agents [source: Richards et al.].
• Cultural mismatch. A cultural gap between therapist and patients limited the addiction work [source: Savage & McCabe].
• Research problems. Blinding failed, controls were lacking, and suggestion, enthusiasm and expectation could not be ruled out [source: Pahnke 1969; Leuner; Richards et al.].

Problems a present-day clinician meets, with responses [synthesis unless tagged]:

• A client asks you to run or attend a Spring Grove-style session. Decline clearly and explain the legal and ethical limits. Offer harm-reduction assessment and integration (B3), and point to regulated trials.
• A client is idealising a past experience and wants to repeat it to fix current problems. Explore what the experience stands for, and test it against current goals. Use B2 to set realistic expectations.
• A former participant or relative is distressed (intrusive memories, anger about consent, especially among people who were imprisoned). Validate the distress. Assess for trauma symptoms and use standard trauma-focused care. Help the client obtain records where possible, and explore any complaint or legal routes they choose. The specific routes for historical research complaints are not covered in the sources [uncertain].
• Destabilisation after recent outside use (anxiety, depersonalisation, persistent perceptual change, psychotic symptoms, suicidal thoughts). Do a standard risk assessment, arrange an urgent psychiatric or medical referral, ground and stabilise the client, and pause exploratory work. Discuss means only as lethal-means counselling requires: safe storage and removal.
• A spiritual emergency or rigid metaphysical conclusions. Respect the client's framework without endorsing it. Assess functioning and sleep, and screen for mania or psychosis. Slow the pace, and involve faith advisers if the client wishes.
• Rupture, when the client feels you are dismissive of their experience or of the research. Name the rupture, acknowledge the historical value of the work, and separate curiosity about the experience from your legal limits.
• You notice your own enthusiasm. Spring Grove's authors named therapist enthusiasm as a possible driver of results [source: Richards et al.]. Monitor in supervision whether your hopes for psychedelic medicine are shaping your advice.
• A colleague claims lineage or offers "guided sessions". Use B6. Consult your professional body about duties to report unlicensed or illegal practice; these duties vary by jurisdiction [uncertain].

Sources

Sources:

• Spring Grove Experiment – Wikipedia
• Richards, Grof, Goodman & Kurland, LSD-Assisted Psychotherapy and the Human Encounter with Death (MAPS bibliography PDF)
• Richards, Psychedelic Drug-Assisted Psychotherapy with Persons Suffering from Terminal Cancer, J. Altered States of Consciousness 1979–80 (MAPS bibliography PDF)
• Pahnke, Kurland, Unger, Savage & Grof, The Experimental Use of Psychedelic (LSD) Psychotherapy (MAPS bibliography PDF)
• Savage & McCabe, Residential Psychedelic (LSD) Therapy for the Narcotic Addict, Arch Gen Psychiatry 1973 (MAPS bibliography PDF)
• Pahnke, The Psychedelic Mystical Experience in the Human Encounter with Death, Harvard Theological Review 1969 (MAPS bibliography PDF)
• Leuner, Hallucinogens as an aid in psychotherapy: basic principles and results, in 50 Years of LSD (MAPS bibliography PDF)
• MAPS Bulletin, LSD Research in the 1990's
• University of Calgary, Researcher explores America's longest-running LSD experiment (2016)
• Haslem, "Too Hot to Handle": LSD, Medical Activism, and the Spring Grove Studies, Purdue thesis 2017 (abstract page)

Further reading (not drawn on): books and papers cited:

• Kurland, Unger, Shaffer & Savage (1967). Psychedelic therapy utilizing LSD in the treatment of the alcoholic patient: a preliminary report. American Journal of Psychiatry.
• Kurland, Savage, Pahnke, Grof & Olsson (1971). LSD in the treatment of alcoholics. Pharmakopsychiatrie.
• Grof, S. (1980). LSD Psychotherapy.
• Grof, S. & Halifax, J. (1977). The Human Encounter with Death.
• Yensen, R. & Dryer, D. Thirty years of psychedelic research: the Spring Grove experiment and its sequels.

These further-reading sources are not drawn on for claims except as reported in the sources above [uncertain].